Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Japan

Japan Articles

Industry

BMI View: Takeda will continue to underperform its rivals over the medium term. Sales, net income and earnings per share (EPS) all declined in the most recent financial reporting period.... 2010-08-06


Industry

BMI Core View: The development and marketing of therapeutics in combination with diagnostics will become more common. It is increasingly clear that the 'one size fits all' approach... 2010-08-02


Industry

BMI Core View: Personalised medicines will play a greater role in the treatment of patients. They offer fewer side-effects and treat illnesses more efficiently than wide-spectrum therapeutics.... 2010-07-28


More ARTICLES

Industry

BMI Core View: Offshoring manufacturing to low cost bases will accelerate. Multinational drugmakers are looking to cut costs ahead of the patent cliff and production is being shifted... 2010-07-26


Industry

A leading Japanese manufacturer of generic drugs, Sawai Pharmaceutical, is looking to partner with a larger drugmaker to grow its domestic business. 'Our sales are strong now, but when... 2010-07-02


Industry

Like other Japanese pharmaceutical companies, Eisai is conservative in nature and outlook. The Tokyo-based firm generates the majority of revenue in its domestic market and the US.... 2010-06-29


Industry

Multinational drugmaker Sanofi-Aventis is to invest JPY5bn (US$55mn) to obtain a 5% stake in Japanese drugmaker Nichi-Iko, making it the second largest shareholder in the company, after... 2010-05-27


Industry

Japan-based Panasonic has announced expansion plans for its Singapore research and development (R&D) centre, which currently focuses on the audiovisual, automotive, computer and... 2010-04-26